Clinical value of matrix metalloproteinase-2 and -9 in ultrasound-guided radiofrequency ablation treatment for papillary thyroid carcinoma

OBJECTIVE: This study aimed to investigate serum matrix metalloproteinase (MMP)-2 and MMP-9 levels in patients with papillary thyroid carcinoma (PTC). METHODS: Forty-one patients with PTC undergoing ultrasound-guided radiofrequency ablation (RFA) and 56 controls were included. Serum MMP-2 and MMP-9...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qunyan, Yuan, Tao, Ding, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Prospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418228/
https://www.ncbi.nlm.nih.gov/pubmed/32772889
http://dx.doi.org/10.1177/0300060520917581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418228/
https://www.ncbi.nlm.nih.gov/pubmed/32772889
http://dx.doi.org/10.1177/0300060520917581

Ejemplares similares